Effect of Ketosis on Pain and Quality of Life in Patients With Lipedema
Lipodiet
The Norwegian LIPODIET Study: Effect of Ketosis on Pain and Quality of Life in Patients With Lipedema
1 other identifier
interventional
70
1 country
2
Brief Summary
Lipedema is a female progressive fat disorder, characterized by a symmetrical increase in subcutaneous adipose tissue in the lower extremities with the exception of the waist. The condition is often misdiagnosed and underdiagnosed. The etiology is poorly understood. Affects about 11% of all women and may lead to pain and immobility. The pathophysiology may be related to sex hormones and inflammatory response. Lipedema fat has been reported not to respond to lifestyle changes or bariatric surgery, both in terms of weight loss and symptom reduction; including pain and quality of life. Clinical research on the effect of dietary interventions on lipedema does not exist, but a pilot study with a ketogenic diet showed a significant reduction in pain regardless of weight loss. The aim of the research project will be to investigate whether a ketogenic diet can be a treatment option for patients with lipedema. Therefore, a randomized controlled trial will be conducted to compare the effects of two diets. 1) energy-restricted ketogenic diet and 3) energy-restricted low-fat non-ketogenic diet for 8 weeks. Pain and quality of life will be mesured at start and immediately after the intervention. The hypothesis is that a ketogenic diet may reduce pain and improve quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2020
CompletedFirst Posted
Study publicly available on registry
November 17, 2020
CompletedStudy Start
First participant enrolled
March 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedMarch 13, 2025
March 1, 2025
2.3 years
November 12, 2020
March 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change in pain intensity
A difference in mean pain score of 2 units on a continuous scale from 0 to 10 on a visual analog scale (VAS) is considered clinically interesting
8 weeks
change in quality of life
Likert Scale
8 weeks
Study Arms (2)
Ketogenic low energy diet
EXPERIMENTALKetogenic low energy diet for 8 weeks
non-Ketogenic low energy diet
ACTIVE COMPARATORnon-Ketogenic low energy diet for 8 weeks
Interventions
Participants will follow a low energy diet, with 1200 kcal per day. Carbohydrates 75g (25E%), protein 60 g (20E%), fat 73 g (55E%) in 8 weeks
Participants will follow a low energy diet, with 1200 kcal per day. Carbohydrates 180g (60E%), protein 60 g (20E%), fat 27 g (20E%), in 8 weeks
Eligibility Criteria
You may qualify if:
- Diagnosed with lipedema by skilled physical therapists
- Body mass index \> 30kg/m2 and \< 45kg/m2
- Stable weight over the last three months (+2-3kg)
- Not currently dieting to lose weight
- Willing to meet for follow-ups every second week during the intervention
- Willing to sign an informed consent before entering the study
You may not qualify if:
- Pregnant or breast feeding
- History of infectious diseases
- Medication known to affect obesity
- Enrolled in any other obesity treatment
- Having had bariatric surgery.
- Kidney disease is excluded
- History of psychological disorders
- Not mastering a Scandinavian language
- Being mentally disabled
- Malign disease
- Diabetes
- Any disease that leads to dietary advice that is not consistent with intervention advice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Helse Nord-Trøndelag HFlead
- Norwegian University of Science and Technologycollaborator
- St. Olavs Hospitalcollaborator
- Vanderbilt University Medical Centercollaborator
Study Sites (2)
Levanger Hospital, Nord-Trøndelag Hospital Trust
Levanger, Norway
St Olavs Hospital
Trondheim, Norway
Related Publications (3)
Lundanes J, Nes VF, Aakervik O, Ryan L, Hansson P, Rokstad AM, Martins C, Nymo S. Changes in Cytokines and Fibrotic Growth Factors after Low-Carbohydrate or Low-Fat Low-Energy Diets in Females with Lipedema. Curr Dev Nutr. 2025 Feb 20;9(3):104571. doi: 10.1016/j.cdnut.2025.104571. eCollection 2025 Mar.
PMID: 40125475DERIVEDLundanes J, Garseth M, Taylor S, Crescenzi R, Pridmore M, Wagnild R, Hyldmo AA, Martins C, Nymo S. The effect of a low-carbohydrate diet on subcutaneous adipose tissue in females with lipedema. Front Nutr. 2024 Nov 7;11:1484612. doi: 10.3389/fnut.2024.1484612. eCollection 2024.
PMID: 39574523DERIVEDLundanes J, Storlilokken GE, Solem MS, Dankel SN, Tangvik RJ, Odegard R, Holst JJ, Rehfeld JF, Martins C, Nymo S. Gastrointestinal hormones and subjective ratings of appetite after low-carbohydrate vs low-fat low-energy diets in females with lipedema - A randomized controlled trial. Clin Nutr ESPEN. 2025 Feb;65:16-24. doi: 10.1016/j.clnesp.2024.11.018. Epub 2024 Nov 19.
PMID: 39566600DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Siren Nymo, PhD
Nord-Trøndelag Hospital Trust, Namsos Hospital, Clinic of Surgery
- STUDY DIRECTOR
Hallvard Græslie, md
Nord-Trøndelag Hospital Trust, Namsos Hospital, Clinic of Surgery
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2020
First Posted
November 17, 2020
Study Start
March 22, 2021
Primary Completion
July 1, 2023
Study Completion
April 1, 2025
Last Updated
March 13, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share